Laurus Labs Ltd - 540222 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
USFDA Inspection at Laurus Synthesis Private Limited12-12-2023
12-12-2023
Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of ESOPs on December 08, 202308-12-2023
Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor PPT24-11-2023
Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Plant visit at Visakhapatnam and management interaction on December 01, 202324-11-2023
Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
IIFL Invest India Conference, London on Nov 27-28, 202322-11-2023
Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
Update on acquisition21-11-2023
Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Earnings call transcript25-10-2023
Laurus Labs shares tank 11% on weak Q2 earnings, bleak growth outlook by brokerages
Shares of pharma firm Laurus Labs tanked over 11 percent on Monday after the firm reported very weak numbers, missing Street estimates for the quarter ended September 2023 (Q2FY24).23-10-2023
Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio recording of investor call hosted on October 20 202320-10-2023